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Abstract
CD8
+ T cells infiltrate the brain during an anti-viral immune response. Within the brain CD8
+ T cells recognize cells
expressing target antigens, become activated, and secrete IFNc. However, there are no methods to recognize individual
cells that respond to IFNc. Using a model that studies the effects of the systemic anti-adenoviral immune response upon
brain cells infected with an adenoviral vector in mice, we describe a method that identifies individual cells that respond to
IFNc. To identify individual mouse brain cells that respond to IFNc we constructed a series of adenoviral vectors that contain
a transcriptional response element that is selectively activated by IFNc signaling, the gamma-activated site (GAS) promoter
element; the GAS element drives expression of a transgene, Cre recombinase (Ad-GAS-Cre). Upon binding of IFNc to its
receptor, the intracellular signaling cascade activates the GAS promoter, which drives expression of the transgene Cre
recombinase. We demonstrate that upon activation of a systemic immune response against adenovirus, CD8
+ T cells
infiltrate the brain, interact with target cells, and cause an increase in the number of cells expressing Cre recombinase. This
method can be used to identify, study, and eventually determine the long term fate of infected brain cells that are
specifically targeted by IFNc. The significance of this method is that it will allow to characterize the networks in the brain
that respond to the specific secretion of IFNc by anti-viral CD8
+ T cells that infiltrate the brain. This will allow novel insights
into the cellular and molecular responses underlying brain immune responses.
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Introduction
Viruses cause infections in the brain that result in acute disease
of varying severity associated with clearance of the virus, or in
chronic progressive disease associated with virus persistence. CD8
+
T cells are critical immune effectors for viral clearance [1,2] [3,4];
failure of CD8
+ T cell effector function is associated with persistent
infection of humans (i.e., HIV and hepatitis C virus), and mice
(i.e., lymphocytic choriomeningitis virus) [5,6,7].
The functions of CD8
+ T cells known to be important for virus
clearance include their specificity for target antigens, cytotoxic
activity and secretion of effector cytokines, and their capacity to
migrate and localize to tissue sites of virus infection [8] [9]. In vivo,
effector CD8
+ T cells establish immunological synapses with target
cells; immunological synapses constitute the anatomical substrate
that facilitate the functional interactions of T cells with their
specific targets [10,11,12,13,14,15,16,17]. Also, immunological
synapses restrict the cytotoxic effects of T cells exclusively to their
targets; whether they also act similarly to restrict the effects and
diffusion of effector cytokines remains unknown –there is evidence
that many cytokines may either be secreted diffusely from T cells,
or leak out of the immunological synapse – [18,19,20].
In some cases, viral infections in the brain could be limited by
noncytolytic mechanisms such as IFN-c [21]. Noncytolytic
clearance of Sindbis virus has been described [22]. http://www.
plospathogens.org/article/findArticle.action?author=Burdeinick-
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23523Kerr&title=Noncytolytic%20clearance%20of%20Sindbis%20vir-
us%20infection%20from%20neurons%20by%20gamma%20in-
terferon%20is%20dependent%20on%20Jak/STAT%20signaling.
To what degree different viruses are controlled in vivo through
cytotoxic vs. non-cytolytic mechanisms remains to be determined.
Adenoviral vectors are powerful gene transfer tools for
transgene expression in the brain. Adenoviral vectors transduce
a variety of brain cells, including astrocytes, and allow long term
widespread transgene expression if injected directly and carefully
into the brain parenchyma [23]. In the presence of an anti-
adenovirus immune response transgene expression and vector
genomes are eliminated [17,23,24] [25]. The immune response to
viral vectors is an important challenge to gene therapy, as killing of
transduced cells will counter therapeutic benefits.
Long term gene transfer in humans is limited by preexisting
anti-adenoviral immunity, or when animals become immunized
against adenovirus, as the adaptive immune response reduces
transgene expression [17,23,26,27,28,29] [13]. In the context of
this interaction IFN-c becomes polarized at intercellular junctions
between T cells and infected astrocytes [13].
Upon IFNc release and binding to its receptor on target cells,
IFNc signals through the JAK-STAT pathway. This causes
phosphorylation of STAT1; dimers of phosphorylated STAT1
translocate to the nucleus where, upon binding to specific IFNc
response elements (known as Gamma Activated Sites or GAS),
they activate expression of a large number of IFNc-inducible genes
[30]. Subsequent expression of IFNc-induced proteins is respon-
sible for the antiviral effects of IFNc.
To identify brain cells that have been exposed to IFNc we
developed a new detection system. Three adenoviral vectors
containing the GAS element driving expression of the transgene
Cre recombinase were produced. One vector did not contain any
transgene in addition to the IFNc-inducible Cre recombinase (Ad-
GAS-Cre), a second one contained eGFP under the transcriptional
control of a constitutive promoter (Ad-eGFP-GAS-Cre), and the
third vector contained the HSV1-TK gene under the control of a
constitutive MIE-hCMV promoter (Ad-TK-GAS-Cre). Cre re-
combinase was chosen as a transgene –the enzyme is identified by
immunocytochemistry, as it becomes concentrated in the nucleus
of target cells-.
To determine the efficiency of our vectors to detect IFNc release
in the brain we injected the reporter adenoviral vectors into the
brain, and at a later time, induced a systemic immune response to
adenovirus, leading to the infiltration of the brain with antiviral
CD8
+ T cells, close interaction with the infected cells and
predicted release of IFN-c. As we detected expression of Cre
recombinase, with all three vectors, we conclude that our vectors
can be used as reporters to monitor the cellular targets of IFNc
secretion in the brain in vivo, during anti-viral immune responses.
Materials and Methods
Ethic statement
All animal work has been conducted according to relevant
national and international guidelines. The work described was
approved by the Institutional Animal Care and Use Committee at
Cedars-Sinai Medical Center and conformed to the policies and
procedures of the Cedars-Sinai Medical Center Comparative
Medicine Department, and was approved under IACUC protocol
number 2090.
Adenovirus vector constructions
Ad-GAS-Cre, Ad-eGFP-GAS-Cre, and Ad-TK-GAS-Cre are
first-generation, replication defective serotype 5 adenovirus with
deletions in the E1 and E3 regions. Ad-GAS-Cre is a novel vector
constructed to detect IFNc targeted cells. Ad-GAS-Cre encodes
for Cre recombinase (a Type I topoisomerase from P1 bacterio-
phage) driven by an Interferon gamma activated sequence (GAS).
Briefly, the GAS element was excised by BamHI digestion from
pGAS-Luc (Stratagene, La Jolla) and cloned into pSP72,
generating pSP72-GAS-pA (3,362 bp). An extended version of
Cre recombinase (nls Cre) encoding the nuclear localization signal
(nls) from pSV40 large T antigen [31] was PCR amplified with
specific primers designed introducing a TATA box in the 59
extreme and flanking XbaI sites: Cre For 59-GCTCTAGAGC-
TATATAATGGCACCCAAGAAGAAGAGGAAGGTGTCC-
39 Cre Rev 59GCTCTAGAGCCTAATCGCCATCTTGCAG-
CAGGCGCACCATTGCCCC-39; and then cloned into the
XbaI site of pSP72-GAS-pA, generating pSP72-GAS-Cre
(4,411 bp). The GAS-cre cassette was excised from pSP72GAS-
Cre by BglII digestion and ligated into pDE1sp1A (6,409 bp),
generating pDE1sp1A-GAS-Cre (7,387 bp) (Figure 1A,
Figure S1).
Ad-hCMV.eGFP-GAS-Cre (Ad-eGFP-GAS-Cre) is a novel
bicistronic adenovirus vector encoding: (i) enhanced green
fluorescent protein (eGFP) gene driven by the human cytomeg-
alovirus intermediate-early promoter (hCMV), (ii) GAS-Cre
cassette. The pDE1sp1A-hCMV.eGFP plasmid was generated by
cloning the hCMV.eGFP cassette from pAL119.eGFP into the
BglII site of pDE1sp1A-GAS-Cre (Figure 1B, Figure S2).
Ad-hCMV.TK-GAS-Cre (Ad-TK-GAS-Cre) is a novel bicis-
tronic adenovirus vector encoding: (i) HSV-1 Thymidine Kinase gene
driven by the human cytomegalovirus intermediate-early promot-
er (hCMV), (ii) GAS-Cre cassette. The pDE1sp1A-hCMV.TK
plasmid was generated by cloning the hCMV.TK cassette from
pAL119TK into the HindIII site of pDE1sp1A. The GAS-cre
cassette was excised from pSP72GAS-Cre by BglII digestion and
ligated into pDE1sp1A-hCMV.TK, generating pDE1sp1A-
hCMV.TK-GAS-Cre (10,329 bp) (Figure 1C, Figure S3).
Ad-0, Ad-IFNc [32], Ad-IFNa, and Ad-HPRT have been
described elsewhere [33]. First generation vectors were scaled up
as described previously [33]. Vector preparations were screened
for the presence of replication competent adenovirus and for
lipopolysaccharide contamination (Cambrex, East Rutherford, NJ)
[33]. Virus preparations used were free from replication
competent adenovirus and lipopolysaccharide contamination.
Animals and surgical procedures
Female B6;129-Gt(ROSA)26Sor
tm1Sho/J (ROSA26) (Jackson Lab-
oratories, Bar Harbor, ME) were injected into the right striatum as
previously described with either 1610
7 iu of Ad-GAS-Cre, Ad-
TK-GAS-Cre, or Ad-eGFP-GAS-Cre. Two weeks later animals
were injected systemically (intraperitoneal: ip) with either
5610
8 iu of Ad-HPRT in 100 ml of solution or saline. Four weeks
after systemic immunization with adenovirus, mice were anesthe-
tized using ketamine (75 mg/kg) and dex-medetomidine (0.5 mg/
kg). At experimental endpoints mice were anesthetized and
perfused-fixed and brains were processed for immunohistochem-
istry. Spleens were harvested during anesthesia, before perfusion,
and processed for splenocyte isolation as described elsewhere [34].
Spleen cells were stored in liquid nitrogen until used.
C57/Bl6 mice (n=2) were stereotactically injected bilaterally
with 1610
7 of Ad-eGFP-GAS-Cre and 21 days later with either
Ad-0, Ad-IFNc, or Ad-IFNa (1610
7 iu). Mice were euthanized 14
days later and brain sections were assessed by ICC for Cre
recombinase. The numbers of Cre recombinase immunoreactive
cells and eGFP expressing cells were quantified by stereology.
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Coronal brain sections (50 mm thick) were used for immuno-
histochemistry to detect transgene expression or specific immune
cells using methodologies described previously [33]. The primary
antibodies used for immunohistochemical staining were the
following: rabbit polyclonal anti-Cre recombinase (1:10,000)
(Novagen), rabbit polyclonal anti-HSV1-TK (1:10,000) (produced
by us) and rat anti-mouse CD8a (1:5,000) (Serotec, Raleigh, NC).
Appropriate secondary antibodies were used: biotin-conjugated
goat anti-rabbit immunoglobulin G (1:800), biotin-conjugated goat
anti-rat immunoglobulin G (1:800) (DAKO, Glostrup, Denmark),
Alexa 488-conjugated goat anti-rabbit (1:1,000), Alexa 594-
conjugated goat anti-rat (1:1,000), Alexa 647-conjugated goat
anti-rat (1:1,000) (Molecular Probes, Carlsbad, CA).
Quantification and stereological analysis
The number of labeled cells was quantified using a Zeiss
AxioPlan 2 Imaging microscope (Carl Zeiss Microsystems,
Thornwood, NY) controlled by a Ludl electronic MAC 5000
XY stage control (Ludl Electronics Products, Hawthorne, NY),
and Stereo Investigator software [35]. Data was expressed as an
absolute number of positive cells in each anatomical region
analyzed. Results were expressed as the mean 6SEM.
Confocal imaging
Sections were examined using a Leica DMIRE2 confocal
microscope (Leica Microsystems) and Confocal Software (Leica
Microsystems), as described previously [16].
Figure 1. Description of novel viral vectors. Schematic illustration depicting the IFNc inducible expression of Cre recombinase in (A) Ad-GAS-
Cre; (B) Ad-eGFP-GAS-Cre; and (C) Ad-TK-GAS-Cre. The figure illustrates that Cre recombinase is only expressed in the presence of IFNc; eGFP and
HSV1-TK are expressed constitutively. ‘‘On’’ and ‘‘Off’’ refers to the inducible expression from the IFNc responsive GAS promoter.
doi:10.1371/journal.pone.0023523.g001
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As a measure of the cell-mediated immune response to
adenovirus we assessed the frequency of IFN-c-producing T cells
using the ELISPOT kit assay (R&D Systems, Minneapolis, MN)
according to the manufacturer’s instructions. Briefly, splenocytes
(1610
6 cells/well) were cultured in Millipore MultiScreen-HA
plates (coated with anti-IFN-c antibody) for 24 hours in X-Vivo
media (Cambrex, Baltimore, MD) containing 1610
9 iu/ml of
heat-inactived Ad-HPRT (inactivated at 85uC, for 15 minutes).
The wells were then washed and incubated overnight at 4uC with
biotinylated anti-IFN-c detection antibodies (R&D Systems,
Minneapolis, MN). Reactions were visualized using streptavidin-
alkaline phosphatase, and 5-bromo-4-chromo-3-indolylphospha-
tase p-toluidine salt, and nitro blue tetrazolium chloride as
substrate [34]. The number of spots per 10
6 splenocytes, which
represents the frequency of IFN-c-producing cells, was counted
with the KS ELISPOT automated image analysis system (Zeiss,
Jena, Germany). Results were expressed as the mean 6SEM.
Depletion of circulating CD8
+ T cells
To determine the optimum timing for the administration of
CD8 T cell depletion naı ¨ve ROSA26 mice were injected i.p. with
0.5 mg of anti-CD8 depleting antibody once; 3, 7 and 8 days post-
depletion two mice were euthanized for the identification of CD8
+
T cells (CD3
+, CD4
2, CD8
+) by flow cytometry (Figure S4). As
the circulating levels of CD8
+ T cells started to recover at 8 days
post-injection of the depleting antibody, CD8-depleting antibodies
were administered every 5 days, from 2 weeks post-systemic
immunization (i.e., day 28, to euthanasia on day 42.
Statistical analysis
Data were analyzed by using a one way analysis of variance
(ANOVA), followed by Tukey’s test, or paired T-test; results were
expressed as the mean 6 SEM. A ‘p’ value ,0.05 was considered
the cut off for significance.
Results and Discussion
Development of a novel system to detect IFNc signaling
in the brain in vivo
To identify and visualize IFN-c secretion onto target cells
during an active immune response against adenovirus, we
generated three novel first generation adenoviral vectors encoding
Cre recombinase under a promoter (GAS) that is inducible upon
IFNc binding and stimulation of the IFNc receptor and its specific
downstream signaling (Figures 1, 2). The schematic genetic
structure of all three vectors, Ad-GAS-Cre, Ad-TK-GAS-Cre, or
Ad-eGFP-GAS-Cre, is shown in Figure 1.
Ad-GAS-Cre was constructed first; upon stimulation with IFNc
Cre recombinase expression was detected demonstrating the
functionality of the GAS-Cre IFNc inducible expression cassette
within first generation adenoviral vectors. However, Ad-GAS-Cre
does not allow to detect transduction of target cells in the absence
of IFNc. Thus, to identify transduced cells during an anti-
adenoviral immune response, and to be able to do so
independently of the presence of IFNc we constructed two
additional vectors, Ad-eGFP-GAS-Cre (Figure 1B), and Ad-TK-
GAS-Cre (Figure 1C). Ad-EGFP-Cre encodes the fluorescent
protein enhanced green fluorescent protein, and Ad-TK-GAS-Cre the
HSV-1 Thymidine Kinase; expression of eGFP and HSV1-TK
are under the control of a constitutive promoter. Vector-mediated
detection of IFNc signaling in target cells is illustrated in Figure 2.
Transient expression of Cre recombinase at early time
points after first generation adenoviral vectors
administration
To determine the existence of any basal expression from our
vectors in the absence of a systemic immune response C57/Bl6
mice were intracranially injected with all three viruses. At 3 days
after injection we detected Cre recombinase expression from all
vectors (Figure 3A). To determine whether early Cre recombinase
expression is stable or transient C57/Bl6 mice were stereotactically
injected bilaterally in the brain striatum with Ad-eGFP-GAS-Cre
and euthanized 3, 7, 14, 21, 28, and 60 days after injection.
Quantification of eGFP expression, an indication of adenovirus
transduction, was stable over 60 days (Figure 3B). Importantly,
expression of Cre recombinase was reduced over time (Figure 3C),
indicating that the early expression is transient. As Cre recombi-
nase expression reached basal levels at 14 days post-injection, and
remained low until 60 days post-injection, it was decided that in
experiments to test the effect of a systemic immune response,
animals would be immunized at 14 days post-delivery of vectors
into the brain, and then sacrificed at either 2 or 4 weeks later to
determine whether the systemic immune response was able to
induce Cre recombinase expression. Administration of systemic
IFNc or IFNa through adenoviral vectors did not increase Cre
recombinase expression in the brain (data not shown).
Cre recombinase is expressed in the brains of mice
during an adenovirus specifc systemic immune response
ROSA26 mice were injected into the right striatum with
1610
7 iu of Ad-Gas.Cre (Figure 4). Two weeks later animals
Figure 2. Schematic of the IFNc signaling pathway, and the use
of GAS-Cre as a reporter of IFNc signaling. Schematic of IFNc
signaling through the JAK/STAT1 pathway. Binding of IFNc to its
receptor results in activation of JAKs, which phosphorylate cytoplasmic
monomers of STAT1. Phosphorylated STAT1 dimerizes, translocates to
the nucleus, and activates transcription from gene promoters
containing Gamma Activated Sites (GAS). Cre recombinase translocates
to the nucleus due to the presence of a nuclear localization signal.
doi:10.1371/journal.pone.0023523.g002
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8 iu of Ad-HPRT or saline. Two
or four weeks after systemic immunization with adenovirus, mice
were euthanized, perfused fixed, and 50 mm thick brain sections
were analyzed for expression of Cre recombinase. To confirm the
efficacy of the immunization, total splenocytes were analyzed for
the frequency of IFNc-secreting immune cells by IFNc ELISPOT
in response to stimulation with adenovirus (Figure 4F). At 2 and 4
weeks post immunization the levels of Cre recombinase expression
in the brain were elevated (Figure 4C, D, E). There was no
difference in the increase of Cre recombinase expression between
males and females (Figure 4E). These data suggest that IFNc
release in the brain following systemic immunization against
adenovirus, mediates an increase in the expression of Cre
recombinase. ROSA26 mice were utilized to determine whether
Cre recombinase expression would remove the STOP sequence
within the endogenous ROSA26 locus and activate expression of
the enzyme b-galactosidase. However, we never were able to
detect expression of b-galactosidase. This suggests that either the
Figure 3. Time course of basal unstimulated Cre recombinase expression following the injection of adenoviral vectors expressing
Cre recombinase. A. Low levels of basal (unstimulated) expression of Cre recombinase was detected 3 days following the intrastriatal injection of
Ad-GAS-Cre, Ad-eGFP-GAS-Cre, and Ad-TK-GAS-Cre, in animals that had not been immunized against adenovirus. To determine the time course of
basal Cre recombinase expression mice (n=2–3/time point) were stereotactically injected bilaterally with 1610
7 iu of Ad-eGFP-GAS-Cre. Mice were
euthanized 3, 7, 14, 21, 28, and 60 days later and brain sections were assessed for eGFP expression (B), and by ICC for Cre recombinase (C). Numbers
of eGFP expressing cells and Cre recombinase immunoreactive cells were quantified by stereology. Note that eGFP expression remained stable over
time, and basal Cre recombinase expression was highest at 3 days post-vector delivery, and decreased thereafter. As minimum basal levels were
reached at 14 days post-vector delivery, and remained low at 28 and 60 days post-injections, these time points were selected for further studies (i.e.,
animals in further experiments were injected into the brain at Day 0, immunized systemically against adenoviral vectors on Day 14, and analyzed at 2
and 4 weeks post-immunization). * p,0.05 comparison of all time points, one-way ANOVA followed by Tukey’s test.
doi:10.1371/journal.pone.0023523.g003
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recombinase expression to achieve the excision of the STOP
sequence, or that the target cells’ physiology is affected by the
immune system, in such a way that proper gene expression
becomes impaired.
Ad-eGFP-GAS-Cre as a tool to visualize the interactions
between CD8
+ T cells and target brain cells
Ad-eGFP-GAS-Cre (1610
7 iu) was injected into the right
striatum of ROSA26 mice (Figure 5). Two weeks later animals
were injected systemically with either 5610
8 iu of Ad-HPRT or
saline. Four weeks after systemic immunization with Ad-HPRT,
mice were euthanized and brain sections were analyzed for the
expression of Cre recombinase and CD8a. Close interactions
between CD8
+ T cells and infected brain cells, and between CD8
+
T and brain cells expressing Cre recombinase, were detected in
immunized animals (Figure 5A). No CD8
+ T cells, or Cre
recombinase expression were detected in saline immunized
animals (data not shown). As morphological changes were detected
in infected cells, which were attributed to eGFP, we sought to
study the detailed responses to systemic immunization utilizing a
different transgene, namely HSV1-TK.
Figure 4. Systemic immunization against adenovirus induces Cre recombinase expression in mice injected with Ad-GAS-Cre. A.
ROSA26 mice (n=5) were stereotactically injected in the striatum with Ad-GAS-Cre, immunized i.p. 14 days later mice with Ad-HPRT or saline; and
euthanized 2 or 4 weeks after immunization; brain sections were assessed by ICC for Cre recombinase. B. Diagram depicting the paradigm for the
IFNc inducible phenotype of Ad-GAS-Cre infected brain cells in our model; i.e., systemic immunization causes nuclear localization of the transgene Cre
recombinase (illustrated as black nuclei upon availability of IFNc). C. Cre recombinase immunoreactivity is increased in striatal cells at 2 and 4 weeks
post-systemic anti-adenoviral immunization; *,p ,0.05 versus saline, by paired T-test. D. Representative micrographs illustrate striatal cells expressing
nuclear Cre recombinase at 2 weeks or 4 weeks post- immunization; E. When discriminated by sex, no significant differences were found in the
number of Cre recombinase expressing cells in the brain of males compared to females in either sham or immunized mice; *,p ,0.05 versus saline, by
paired T-test. F. Total splenocytes were tested to determine the frequency of IFNc secreting lymphocytes specific for adenovirus antigens using
ELISPOT assay. Concavalin A (ConA) was used as a control mitogen. *,p ,0.05 versus saline, by paired T-test.
doi:10.1371/journal.pone.0023523.g004
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virally infected cells in the brain following the systemic
immunization against adenovirus
ROSA26 mice were stereotactically injected in the brain with
Ad-TK-GAS-Cre, immunized 2 weeks later mice with Ad-HPRT
or saline (ip), and euthanized 4 weeks after immunization
(Figure 6A). Serial brain sections were analyzed for the expression
of Cre recombinase, HSV1-TK and CD8a. The number of virally
transduced cells expressing HSV1-TK decreased 4 fold
(Figure 6C). The number of Cre recombinase expressing cells
increased significantly (Figure 6D; shown schematically in
Figure 6B). CD8
+ T cell infiltration in the brain parenchyma
was detected only in adenovirus-immunized animals (Figure 6E).
Increased frequency of IFNc secreting lymphocytes specific for
adenovirus antigens, and detected using an ELISPOT assay, was
detected among total splenocytes (Figure 6F). Our results show
that the systemic adenovirus immune response induces abundant
CD8
+ T cell infiltration of the brain, and an increase in the
expression of Cre recombinase from an IFNc sensitive promoter,
suggesting the presence of elevated IFNc signaling during the loss
of HSV1-TK expression.
CD8
+ T cells are necessary for induction of IFNc-inducible
Cre recombinase expression in vivo, during the loss HSV1-
TK expression from adenoviral vectors
To determine the role of CD8
+ T cells in stimulating IFNc-
inducible Cre recombinase during a systemic anti-adenoviral
immune response, we depleted CD8
+ T cells from animals that
were systemically immunized against adenovirus; CD8
+ T cell was
achieved using a specific depleting antibody (set up experiment is
illustrated in Figure S4). ROSA26 mice were stereotactically
injected in the brain with Ad-TK-GAS-Cre, 2 weeks later
immunized ip with Ad-HPRT. One group of animals was then
injected ip injection of anti-CD8 depleting antibody (or isotype
control) two weeks post-immunization, and followed with
additional injections of depeleting antibodies every 5 days until
euthanasia (Figure 7A). Brain sections were analyzed for the
expression of Cre recombinase and HSV1-TK. The number of
HSV1-TK expressing cells decreased significantly in immunized
animals treated either with no antibodies, or isotype control, while
no decrease was observed in animals treated with the anti-CD8
depleting antibody (Figure 7B). Flow cytometry analysis revealed
effective reduction of CD8
+ T cells (CD3
+CD4
2CD8
+) in the
spleens of mice after treatment with anti-CD8 depleting antibody;
and no difference was detected between groups of animals which
had been immunized and either treated with isotype control
antibody or none (Figure 7C). We also determined the number of
cells in which we could still detect HSV1-TK, but were otherwise
atrophied, as they were devoid of normal cellular processes shown
by cells in non-immunized animals (Figure 7D); In parallel, the
number of Cre recombinase expressing cells increased in
immunized animals that were injected with either isotype antibody
or no antibody, but increased much less in immunized animals
depleted of CD8
+ T cells (Figure 7E). These results suggest that
IFNc induces expression of Cre recombinase and that this nuclear
expression remains detectable in cells otherwise undergoing
atrophy in response to the immune attack, and that CD8
+ T cells
are the main producers of IFNc in the brain during the antiviral
immune response, and thus, directly responsible for the activation
of Cre recombinase expression in target cells.
Conclusions
In order to fully understand the cellular and molecular
dynamics of the brain immune response, it is important to be
able to determine which target cells are influenced during the
brain infiltration with CD8
+ T cells, as these aim to clear the brain
from virally infected cells. To determine which cells in the brain
respond to IFNc secreted from T cells upon activation, we
developed a series of viral vectors encoding an IFNc responding
element. Using these vectors we demonstrate that widespread
IFNc signaling does indeed occur, as it can be effectively detected
in a large amount of target cells during immune-mediated
Figure 5. Systemic immunization against adenovirus induces Cre recombinase expression in brain cells infected with Ad-eGFP-GAS-
Cre. ROSA26 mice (n=5) were stereotactically injected in the brain with Ad-eGFP.GAS-Cre, immunized i.p. 14 days later with Ad-HPRT or saline, and
euthanized 4 weeks post-immunization; brain sections were assessed by ICC for Cre recombinase and CD8a A. Representative micrographs illustrate
cells expressing Cre recombinase (grey), eGFP (green), and CD8+ T cells (red) in the striatum of immunized mice. Notice that in some cases close
apposition between T cells and infected cells expressing Cre recombinase was detected, while other cells expressing Cre recombinase did not have an
associated T cell, indicating the likely diffusion of IFNc throughout the tissue; B. Diagram depicting the paradigm for the IFNc inducible phenotype of
Ad-eGFP-GAS-Cre infected brain cells in our model; i.e., systemic immunization causes nuclear localization of the transgene Cre recombinase
(illustrated as dark nuclei upon availability of IFNc, within green cells expressing eGFP).
doi:10.1371/journal.pone.0023523.g005
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numbers of Cre recombinase expressing cells during the peak of the
brain infiltration with anti-viral T cells suggests a large amount of
IFNc activity. The atrophic nature of remaining cells expressing
Cre recombinase and HSV1-TK, together with their inability of
expressing b-galactosidase, suggests that brain cells targeted by the
Figure 6. Systemic immunization against adenovirus induces Cre recombinase expression in brain cells infected with Ad-TK-GAS-
Cre. A. ROSA26 mice (n=5) were stereotactically injected in the brain with Ad-TK-GAS-Cre, immunized i.p. 14 days later with Ad-HPRT or saline, and
euthanized 4 weeks after immunization. B. Diagram depicting the paradigm for the IFNc inducible phenotype of Ad-TK-GAS-Cre infected brain cells
in our model; i.e., systemic immunization causes nuclear localization of the transgene Cre recombinase (illustrated as dark nuclei upon availability of
IFNc, within grey cells expressing HSV1-TK). C. HSV1-TK immunoreactivity was used to quantitate levels of viral transduction in the brain, and
illustrates the decrease in HSV1-TK transgene expression upon immunization. D. Cre recombinase immunoreactivity was used to quantitate the level
of IFNc dependent signaling during the anti-adenoviral systemic immune response. E. Micrographs depict cells expressing HSV1-TK (left panel), CD8
+
T cells (middle panel), and Cre recombinase (right panel) staining in representative striatal sections from saline treated or mice immunized with Ad-
HPRT. F. Total splenocytes were assessed for the frequency of IFNc secreting lymphocytes specific for adenovirus antigens using ELISPOT assay.
Concavalin A (ConA) was used as a control mitogen. *,p ,0.05 versus saline, by paired T- test.
doi:10.1371/journal.pone.0023523.g006
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Together with many other data demonstrating the loss of
transduced cells in this and similar paradigms, suggests that the
immune response is able to eliminate transduced cells from the
brain, or seriously damage their physiology. Our data demonstrate
that IFNc signaling occurs in target cells during the brain antiviral
immune responses. Our novel method could be used further to
study the in vivo dynamics of IFNc secretion and signaling onto
Figure 7. CD8
+ T cells are necessary to induce IFNc-dependent Cre recombinase expression following the systemic immunization
against adenoviral vector. A. ROSA26 mice were stereotactically injected in the striatum with Ad-TK-GAS-Cre, immunized i.p. 14 days later with
Ad-HPRT. This was followed by the ip injection of 0.5 mg of anti-CD8 depleting antibody (or isotype control, or no antibody) every 5 days until
euthanasia, which was performed at 4 weeks after immunization. Brain sections were assessed by ICC for Cre recombinase and HSV1-TK. B. HSV1-
TK immunoreactivity was used to quantitate the levels of morphologically intact virally transduced cells; note that the number of morphologically
intact HSV1-TK expressing cells is reduced upon immunization, and this effect is inhibited by the depletion of circulating CD8
+ T cells. C. Flow
cytometry was used to determine the percentage of CD8
+ T cells (CD3
+CD4
2CD8
+) in the spleen of mice; note that the increase of adenovirus-
specific CD8
+ T cells caused by systemic anti-adenovirus immunization is reduced by treatment with CD8-depleting antibodies. D. HSV1-TK
immunoreactivity was used to quantitate the levels of morphologically atrophic virally transduced cells in the brain –atrophic cells were
characterized by the lack of cellular processes, and mainly consisted of cell bodies-; E. Cre recombinase immunoreactivity was used to quantitate
the level of IFNc-dependent signaling in the brain during the anti-adenoviral immune response; note that Cre recombinase expression is increased
upon immunization, but blocked by the treatment of animals with CD8-depleting antibodies; *,p ,0.05 versus naı ¨ve or CD8-depleted mice by one-
way ANOVA followed by Tukey’s test.
doi:10.1371/journal.pone.0023523.g007
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mune pathology.
Supporting Information
Figure S1 Cloning strategy illustrating the molecular construc-
tion of pDE1sp1A-GAS-Cre (i) Luc gene was cut from pGAS-Luc
with XbaI, then pGAS was cut with BamHI and cloned into the
BglII site of pSP72BglII to make pSP72-GAS-PolyA; (ii) nlsCre
was cut from pGemTATACre with XbaI and cloned into the
XbaI site of pSP72-GAS-PolyA to make pSP72-GAS-Cre; (iii)
GAS-Cre cassette was cut from pSP72-GAS-Cre with BglII and
cloned into the BglII site of pDE1sp1A to make pDE1sp1A-GAS-
Cre, which was used to construct Ad-GAS-Cre.
(TIF)
Figure S2 Cloning strategy illustrating the molecular develop-
ment of pDE1sp1A-hCMVEGFP-GAS-Cre adenovirus genome
plasmids. (i) The hCMV eGFP polyA cassette was excised from
pAL119eGFP (8,178 bp) by HindIII digestion, extremes were
blunted and cloned into EcoRV site of pDE1sp1A, generating
pDE1sp1A-hCMV.eGFP (7,923 bp). (ii) The GAS-Cre-polyA
cassette from pSp72.GAS-polyA (3,374 bp) was excised with BglII
and cloned into the BglII site of pDE1sp1A.hCMV.eGFP,
generating pDE1sp1A-hCMV.eGFP-GAS-nlsCre (9,969 bp),
which was used to construct Ad-eGFP-GAS-Cre.
(TIF)
Figure S3 Cloning strategy illustrating the molecular construc-
tion of pDE1sp1A-hCMVTK-GAS-Cre adenovirus genome
plasmids. The GAS-Cre cassette was cut from pSP72-GAS-Cre
with BglII and cloned into the BglII site of pDE1sp1A –hCMVTK
to make pDE1sp1A-hCMVTK-GAS-Cre, which was used to
construct Ad-TK-GAS-Cre.
(TIF)
Figure S4 Testing of the CD8
+ T cell depletion paradigm. A.
Naı ¨ve ROSA26 mice were injected i.p. with 0.5 mg of anti-CD8
depleting antibody once. 3, 7 and 8 days post-depletion two mice
were euthanized for the identification of CD8+ T cells (CD3
+,
CD4
2, CD8
+) by flow cytometry, shown in B in the spleen, and in
C, in the cervical draining lymph nodes. As the number of CD8+
T cells started to recover at 8 days post-injection of the depleting
antibody, we injected depleting antibody every 5 days.
(TIF)
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